Reuters Health News Summary

Following is a summary of current health news briefs. New Zealand's largest city Auckland back to lockdown after COVID-19 case

New Zealand's Prime Minister Jacinda Ardern said on Saturday that the country's biggest city, Auckland, will go into a seven-day lockdown from early morning on Sunday after a new local case of the coronavirus of unknown origin emerged. This comes two weeks after Auckland's nearly 2 million residents were plunged into a snap three-day lockdown when a family of three were diagnosed with the more transmissible UK variant of the new coronavirus that causes COVID-19. Romania ships first batch of AstraZeneca vaccine to Moldova

Romania shipped its first donation of AstraZeneca's COVID-19 vaccine to neighbouring Moldova on Saturday to allow Moldova to start vaccinating frontline medical workers next week. Moldova and neighbouring Ukraine, two of Europe's poorest countries, have lagged behind the rest of the continent in the scramble for vaccines and welcomed donations from friendly governments. South Korea vaccinates 18,000 to start ambitious COVID-19 campaign

South Korea said 18,489 people received their first doses of AstraZeneca PLC's vaccine by midnight on Friday as it launched an ambitious COVID-19 inoculation campaign, and will begin using Pfizer/BioNTech vaccines on Saturday. The first to receive the shots are healthcare workers, staffers at assisted care facilities and other high-risk people, with a goal of vaccinating 32 million to 36 million people - some 60% to 70% of the population - by September. U.S. near authorization of Johnson & Johnson COVID-19 vaccine

U.S. regulators on Friday said they would work quickly to authorize Johnson & Johnson's COVID-19 vaccine for emergency use after a panel of outside advisers backed the one-shot immunization. The Food and Drug Administration is expected to decide on emergency use by Saturday for what would be the third vaccine available in the United States, and the only one that requires a single shot. AstraZeneca vaccine made in India to arrive in Canada on Wednesday

A shipment of 500,000 doses of the COVID-19 vaccine developed by AstraZeneca and Oxford University and made by the Serum Institute of India is set to arrive in Canada on Wednesday, the chief executive of local partner Verity Pharmaceuticals said on Friday. Verity's chief executive, Howard Glase, said the shipment is not part of Canada's allocation from the COVAX system, meant to ensure equitable vaccine distribution. Canada has a separate procurement deal with AstraZeneca, which licensed the vaccine to Serum Institute, the world's largest vaccine producer. Russian scientists say Sputnik V performs well against COVID mutations

A Russian trial testing the effectiveness of revaccination with the Sputnik V shot to protect against new mutations of the coronavirus is producing strong results, researchers said on Saturday. Last month President Vladimir Putin ordered a review by March 15 of Russian-produced vaccines for their effectiveness against new variants spreading in different parts of the world. U.S. administers 70.5 million doses of COVID-19 vaccines: CDC

The United States has administered 70,454,064 doses of COVID-19 vaccines in the country as of Friday morning and distributed 94,300,910 doses. The tally of vaccine doses are for both Moderna and Pfizer/BioNTech, vaccines as of 6:00 a.m. ET on Friday, the agency said. Italy reports 280 coronavirus deaths on Saturday, 18,916 new cases

Italy reported 280 coronavirus-related deaths on Saturday against 253 the day before, the health ministry said, while the daily tally of new infections declined to 18,916 from Friday's 20,499. Some 323,047 tests for COVID-19 were carried out in the past day, compared with 325,404 previously, the ministry said. "Things are tenuous," U.S. CDC says as downward trend in COVID-19 cases stalls

The head of the U.S. Centers for Disease Control and Prevention said on Friday that a recent decline in COVID-19 cases may be stalling, a development she described as concerning while urging that safeguards to fight the virus remain in place. Dr. Rochelle Walensky told reporters the number of cases had been increasing for the past three days compared to the prior week and that declines in hospitalizations and deaths were also "potentially leveling off at still a very high number."

U.S. CDC says risk of Ebola to the United States is extremely low The U.S. Centers for Disease Control and Prevention said it was closely following outbreaks of Ebola in Democratic Republic of Congo (DRC) and Guinea, and said the risk of Ebola to the United States was extremely low. "Out of an abundance of caution, the U.S. government will institute public health measures for the very small number of travelers arriving from the DRC and Guinea," the CDC said in a statement late on Friday.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)